Biotechnology
Salix Pharmaceuticals, Ltd. today announced that as early as two weeks into treatment, patients with mild-to-moderate active ulcerative colitis taking 3.3 g balsalazide disodium tablets twice-daily versus placebo for active disease management experienced
06:30 May 20, 2008
Advanced Analytical Technologies, Inc. , based inAmes, IA will unveil its newest instrument platform, the DNA PROfiler system, at BIO 2008. This instrument is being designed to significantly decrease the time to identify infections which could help clini
06:03 May 20, 2008
Data presented today at the International Conference of the American Thoracic Society demonstrate that Perforomist Inhalation Solution has a pharmacodynamic and pharmacokinetic profile that is comparable to the dry powder inhaler formulation of formotero
05:53 May 20, 2008
Data presented today at the International Conference of the American Thoracic Society demonstrate that concomitant therapy with Perforomist Inhalation Solution , delivered by nebulization, and Spiriva is significantly more effective than treatment with t
05:53 May 20, 2008
Recognizing National Hepatitis B Awareness Week May 19 - 23, 2008, the Hepatitis B Foundation and the Association of Asian Pacific Community Health Organizations is hosting a Congressional briefing, "Zero Tolerance for Hepatitis B: the Health Needs
05:43 May 20, 2008
Miraculins Inc. , a biotechnology company dedicated to the discovery and development of diagnostic tools and therapeutic products for cancer, announces today that it will be conducting a 2nd pivotal pre-biopsy screen study for its urine based P2V prostat
05:04 May 20, 2008
ICU patients are nearly one-third less likely to die, on average, when treated at hospitals using the eICU care delivery model, according to results released today by VISICU, Inc. .
05:03 May 20, 2008
Miraculins Inc. , a biotechnology company dedicated to the discovery and development of diagnostic tools and therapeutic products for cancer, announces today that it will be conducting a 2nd pivotal pre-biopsy screen study for its urine based P2V prostat
04:57 May 20, 2008
American Oriental Bioengineering, Inc. , a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products inChina, today announced the formati
04:43 May 20, 2008
CryoPort, Inc. , a company developing leading edge, proprietary, technology-driven shipping and storage products for use in the rapidly growing global biotechnology and biopharmaceutical cold chain, today announced plans for the company to present at the
04:40 May 20, 2008
AVI BioPharma, Inc. today announced that Patrick Iversen, Ph.D., AVI's Senior Vice President of Strategic Alliances, is presenting at the TIDES Oligonucleotide and Peptide Technology and Product Development meeting in Las Vegas on Tuesday, May 20, 2008.
04:30 May 20, 2008
Holmes Biopharma, Inc. announces that its clinic in Omaha Nebraska has resumed operations with business as usual. This brief interruption has not affected the ability of the Omaha clinic to carry out services to clients and study participants.
04:26 May 20, 2008
eResearchTechnology, Inc. , , a leading provider of centralized ECG and eClinical technology, ePRO and other services to the pharmaceutical, biotechnology, medical device and related industries, announced today that Richard Baron has informed the company
04:23 May 20, 2008
On May 16, 2008, Chris McGuinn, the Company's Chief Operating Officer, announced his resignation from Medistem Laboratories to pursue other business opportunities.
04:05 May 20, 2008
Urodynamix Technologies Ltd. and Laborie Medical Technologies today announced the U.S. launch of the Tetra Bladder Monitor System, a catheter-free medical device that uses near infrared spectroscopy to aid in the diagnosis of lower urinary tract symptoms
04:04 May 20, 2008
BioMarin Pharmaceutical Inc. today announced that the first patient has initiated treatment in the Phase 1 clinical study of PEG-PAL for the treatment of phenylketonuria . The study is expected to conclude enrollment in the fourth quarter of 2008.
04:03 May 20, 2008
Pipex Pharmaceuticals, Inc. , a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and autoimmune diseases, announced it was issued a United States patent that is part of its CD4 inhibitor pa
04:01 May 20, 2008
Two independent studies showed that FlexPen® was more accurate when delivering insulin than SoloSTAR®, from sanofi-aventis.
04:00 May 20, 2008
CALGARY, May 20 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. today announced that it has been granted U.S. Patent 7,374,752 entitled "Reovirus for the Treatment of Cellular Proliferative Disorders." The claims cover pharmaceutical compositi
03:53 May 20, 2008
Biodel Inc. today announced that Alan Krasner, M.D. has been appointed as the Company's Chief Medical Officer, effective May 27, 2008.
03:33 May 20, 2008
43771 - 43790 of 48576 Stories
<<
<
Next 20 Biotechnology
>
>>
Search News
Daily News
